BRAF V600E
Clinical trials for BRAF V600E explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E trials appear
Sign up with your email to follow new studies for BRAF V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets 'Undruggable' cancer mutations in major trial
Disease control Recruiting nowThis study is testing a new oral drug, S241656, alone and in combination with other cancer therapies. It aims to find a safe and effective dose for adults with advanced cancers, including lung, pancreatic, and colorectal cancers, that have specific genetic mutations like KRAS or …
Matched conditions: BRAF V600E
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt Cancer's survival secrets during treatment
Knowledge-focused Recruiting nowThis study aims to understand how lung cancer cells survive during the first weeks of targeted drug therapy. Researchers will take tumor samples and blood from 100 adults with specific genetic mutations before and after starting treatment. By comparing these samples, they hope to…
Matched conditions: BRAF V600E
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC